Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tribouilloy, C. M.
Right arrow Articles by Lesbre, J.-P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tribouilloy, C. M.
Right arrow Articles by Lesbre, J.-P. M.
(Chest. 2000;118:1685-1689.)
© 2000 American College of Chest Physicians

Plasma Homocysteine and Severity of Thoracic Aortic Atherosclerosis*

Christophe M. Tribouilloy, MD, PhD; Marcel Peltier, MD; Michele C. Iannetta Peltier, MD; Faouzi Trojette, MD; Michel Andrejak, MD and Jean-Philippe M. Lesbre, MD

* From the Department of Cardiology, South Hospital, University of Picardie, Amiens, France.

Correspondence to: Christophe Tribouilloy, MD, PhD, Service de Cardiologie, Hôpital Sud, 80000 Amiens, Cédex, France

Study objectives: Plasma homocysteine level is a risk factor for coronary events, stroke, and peripheral atherosclerotic disease. However, few data are available concerning the relationship between homocysteine level and severity of thoracic aortic atherosclerosis. We hypothesized in this multiplane transesophageal echocardiography (TEE) study that homocysteine level is a marker of the presence and severity of thoracic aortic atherosclerosis.

Design: Cross-sectional study.

Setting: University hospital.

Patients: Risk factors, angiographic features, and TEE findings were analyzed prospectively in 82 valvular patients.

Measurements and results: The following risk factors were recorded: age, gender, hypertension, smoking, lipid parameters, diabetes, body mass index, and family history of coronary artery disease. Plasma levels of homocysteine, vitamin B12, and folic acid were measured for each patient. By univariate analysis, age, diabetes, hypertension, smoking, family history of coronary artery disease, and levels of homocysteine, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were significant predictors of the presence of thoracic aortic plaques. There was a positive correlation between the plasma homocysteine levels and the score of severity of thoracic atherosclerosis (r = 0.48; p = 0.0001) as well as between the homocysteine levels and the grades of severity of aortic intimal changes (p = 0.0008). Multivariate regression analysis revealed that homocysteine was an independent predictor of the presence and severity of thoracic aortic atherosclerosis.

Conclusion: This prospective study indicates that plasma homocysteine level is a marker of severity of thoracic atherosclerosis detected by multiplane TEE. These findings emphasize the role of homocysteine as a marker of atherosclerotic lesions in the major arterial locations.

Key Words: aorta • atherosclerotic plaque • homocysteine • transesophageal echocardiography




This article has been cited by other articles:


Home page
StrokeHome page
S. Sen, A. Hinderliter, P. K. Sen, J. Simmons, V. A. LeGrys, J. Beck, S. Offenbacher, K. Moss, and S. M. Oppenheimer
Association of Leukocyte Count With Progression of Aortic Atheroma in Stroke/Transient Ischemic Attack Patients
Stroke, November 1, 2007; 38(11): 2900 - 2905.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. V. Ovechkin, N. Tyagi, U. Sen, D. Lominadze, M. M. Steed, K. S. Moshal, and S. C. Tyagi
3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L905 - L911.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. S.V. Elkind, R. Sciacca, B. Boden-Albala, S. Homma, and M. R. Di Tullio
Leukocyte Count Is Associated With Aortic Arch Plaque Thickness
Stroke, November 1, 2002; 33(11): 2587 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. P. Burke, V. Fonseca, F. Kolodgie, A. Zieske, L. Fink, and R. Virmani
Increased Serum Homocysteine and Sudden Death Resulting from Coronary Atherosclerosis With Fibrous Plaques
Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1936 - 1941.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Sen, S. M. Oppenheimer, J. Lima, and B. Cohen
Risk Factors for Progression of Aortic Atheroma in Stroke and Transient Ischemic Attack Patients
Stroke, April 1, 2002; 33(4): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. S. Mujumdar, C. M. Tummalapalli, G. M. Aru, and S. C. Tyagi
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR
Am J Physiol Cell Physiol, May 1, 2002; 282(5): C1009 - C1015.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.